152 related articles for article (PubMed ID: 25537220)
1. TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia.
Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martіna ZV
Exp Oncol; 2014 Dec; 36(4):258-61. PubMed ID: 25537220
[TBL] [Abstract][Full Text] [Related]
2. Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia.
Kochethu G; Delgado J; Pepper C; Starczynski J; Hooper L; Krishnan S; Fegan C; Pratt G
Leuk Res; 2006 Sep; 30(9):1113-8. PubMed ID: 16458962
[TBL] [Abstract][Full Text] [Related]
3. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract][Full Text] [Related]
4. In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.
Sturm I; Bosanquet AG; Hummel M; Dörken B; Daniel PT
BMC Cancer; 2005 Aug; 5():105. PubMed ID: 16109171
[TBL] [Abstract][Full Text] [Related]
5. TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia.
Dong HJ; Fang C; Wang L; Fan L; Xu J; Wu JZ; Lu TX; Li JY; Xu W
Med Oncol; 2014 Apr; 31(4):908. PubMed ID: 24615009
[TBL] [Abstract][Full Text] [Related]
6. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
[TBL] [Abstract][Full Text] [Related]
7. The distribution of TP53 gene polymorphisms in chronic lymphocytic leukemia patients, sufferers of Chornobyl nuclear power plant accident.
Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martina ZV
Exp Oncol; 2016 Dec; 38(4):252-256. PubMed ID: 28230820
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of TP53 polymorphic genetic variations in chronic lymphocytic leukemia.
Bilous N; Abramenko I; Saenko V; Chumak A; Dyagil I; Martina Z; Kryachok I
Leuk Res; 2017 Jul; 58():1-8. PubMed ID: 28364582
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
[TBL] [Abstract][Full Text] [Related]
10. Tp53 gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors.
Gemenetzi K; Galigalidou C; Vlachonikola E; Stalika E; Xochelli A; Baliakas P; Karypidou M; Touloumenidou T; Minga E; Douka V; Iskas M; Athanasiadou A; Makris A; Stavroyianni N; Anagnostopoulos A; Hadzidimitriou A; Stamatopoulos K
Leuk Lymphoma; 2017 Mar; 58(3):726-728. PubMed ID: 27686405
[No Abstract] [Full Text] [Related]
11. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
[TBL] [Abstract][Full Text] [Related]
12. TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia.
Zainuddin N; Murray F; Kanduri M; Gunnarsson R; Smedby KE; Enblad G; Jurlander J; Juliusson G; Rosenquist R
Leuk Res; 2011 Feb; 35(2):272-4. PubMed ID: 20870288
[TBL] [Abstract][Full Text] [Related]
13. TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods.
Kantorova B; Malcikova J; Smardova J; Pavlova S; Trbusek M; Tom N; Plevova K; Tichy B; Truong S; Diviskova E; Kotaskova J; Oltova A; Patten N; Brychtova Y; Doubek M; Mayer J; Pospisilova S
Tumour Biol; 2015 May; 36(5):3371-80. PubMed ID: 25527155
[TBL] [Abstract][Full Text] [Related]
14. TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing.
Minervini CF; Cumbo C; Orsini P; Brunetti C; Anelli L; Zagaria A; Minervini A; Casieri P; Coccaro N; Tota G; Impera L; Giordano A; Specchia G; Albano F
Diagn Pathol; 2016 Oct; 11(1):96. PubMed ID: 27724982
[TBL] [Abstract][Full Text] [Related]
15. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
Fabris S; Mosca L; Todoerti K; Cutrona G; Lionetti M; Intini D; Matis S; Colombo M; Agnelli L; Gentile M; Spriano M; Callea V; Festini G; Molica S; Lambertenghi Deliliers G; Morabito F; Ferrarini M; Neri A
Genes Chromosomes Cancer; 2008 Sep; 47(9):781-93. PubMed ID: 18521849
[TBL] [Abstract][Full Text] [Related]
16. TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia.
Malcikova J; Pavlova S; Kozubik KS; Pospisilova S
Hum Mutat; 2014 Jun; 35(6):663-71. PubMed ID: 24415659
[TBL] [Abstract][Full Text] [Related]
17. TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.
Faria MH; Neves Filho EH; Alves MK; Burbano RM; de Moraes Filho MO; Rabenhorst SH
APMIS; 2012 Nov; 120(11):882-9. PubMed ID: 23009112
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.
Rossi D; Cerri M; Deambrogi C; Sozzi E; Cresta S; Rasi S; De Paoli L; Spina V; Gattei V; Capello D; Forconi F; Lauria F; Gaidano G
Clin Cancer Res; 2009 Feb; 15(3):995-1004. PubMed ID: 19188171
[TBL] [Abstract][Full Text] [Related]
19. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
[TBL] [Abstract][Full Text] [Related]
20. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.
Volodko N; Salla M; Eksteen B; Fedorak RN; Huynh HQ; Baksh S
World J Gastroenterol; 2015 Sep; 21(36):10358-66. PubMed ID: 26420962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
